GT Biopharma, Inc. Common Stock (GTBP)

$0.43 +4.82%
EARNINGS ANALYTICS
search

GT Biopharma, Inc. Common Stock (GTBP) has only 1 recorded earnings event on file, so its post-earnings track record is limited. Its biggest recorded post-earnings gain was +33.25% (Nov 14, 2025) and its biggest decline was +33.25% (Nov 14, 2025).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

1

Avg Abs. Movement

±33.25%

Positive %

100.0%

Negative %

0.0%

Historical Earnings Statistics

Date Timing Open High Close Volume Movement % SEC Filing
Nov 14, 2025 ☀ PRE $0.72 $1.14 $0.96 53,082 +33.25% open_in_new
event

Earnings Count

1

Total earnings in dataset

trending_up

Avg Abs. Movement

±33.25%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

Recent SEC Filings

4 most recent
Form Date Filed View on EDGAR
8-K 20260522 open_in_new SEC.gov
10-Q 20260515 open_in_new SEC.gov
EFFECT 20260513 open_in_new SEC.gov
424B3 20260513 open_in_new SEC.gov

Frequently asked about GTBP earnings

How much does GTBP stock move after earnings? expand_more

Over 1 reports, GTBP has moved an average of ±33.25% the session after earnings, closing higher 100.0% of the time.

What was GTBP's biggest post-earnings move? expand_more

GTBP's largest post-earnings gain on record was +33.25% on Nov 14, 2025, and its largest decline was +33.25% on Nov 14, 2025.

Where can I find GT Biopharma, Inc. Common Stock's SEC filings? expand_more

All of GT Biopharma, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers